Learning objectives 

After watching this webinar, participants will: 

• appreciate the current status of LDL-C goal attainment with statins; 
• recognise the residual clinical risk associated with suboptimal LDL-C control; 
• understand the indications of novel LDL-C-lowering medications beyond statins;
• recognise the residual lipid-related risk beyond LDL-C [lipoprotein(a), triglycerides]; and 
• be aware of novel medications to address this risk.

Needs assessment and expected educational outcome

To understand what statins can and cannot do to reduce the dangers from low-density lipoproteins.

Session information

This webinar is designed for Cardiologists, Primary Care Physicians, Nurses & Allied Professions wishing to update their scientific knowledge on the topic.

During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.

Technical settings

The webinar is available on PC and tablets. The use of a smartphone is not recommended.

To answer the MCQs during the live, you must allow pop-up windows.

A high-speed Internet connection is required (minimum 2 Mbps).